Dikoglu E, Pareja F
Adv Exp Med Biol. 2025; 1464():237-257.
PMID: 39821029
DOI: 10.1007/978-3-031-70875-6_13.
Pal M, Das D, Pandey M
World J Surg Oncol. 2024; 22(1):271.
PMID: 39390525
PMC: 11465949.
DOI: 10.1186/s12957-024-03553-9.
Amandi A, Jabbarpour N, Shiva S, Bonyadi M
Curr Genomics. 2024; 24(6):345-353.
PMID: 38327652
PMC: 10845066.
DOI: 10.2174/0113892029268949231104165301.
Otahalova B, Volkova Z, Soukupova J, Kleiblova P, Janatova M, Vocka M
Int J Mol Sci. 2023; 24(6).
PMID: 36982687
PMC: 10051278.
DOI: 10.3390/ijms24065612.
Rishi J, Timme K, White H, Kerns K, Keating A
Biol Reprod. 2023; 108(4):694-707.
PMID: 36702632
PMC: 10106840.
DOI: 10.1093/biolre/ioac218.
DNA Repair Genes Polymorphisms: Impact on Acute Myeloid Leukemia Patients Outcome.
Aref S, El Menshawy N, Abou Zeid T, Gouda E, Abdel Aziz N
Asian Pac J Cancer Prev. 2022; 23(10):3577-3585.
PMID: 36308385
PMC: 9924318.
DOI: 10.31557/APJCP.2022.23.10.3577.
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group.
Toss A, Quarello P, Mascarin M, Banna G, Zecca M, Cinieri S
Curr Oncol Rep. 2022; 24(7):843-860.
PMID: 35320498
PMC: 9170630.
DOI: 10.1007/s11912-022-01213-3.
Gene Signatures Induced by Ionizing Radiation as Prognostic Tools in an In Vitro Experimental Breast Cancer Model.
Calaf G, Crispin L, Roy D, Aguayo F, Munoz J, Bleak T
Cancers (Basel). 2021; 13(18).
PMID: 34572798
PMC: 8465284.
DOI: 10.3390/cancers13184571.
variants of uncertain significance in clinical practice: A case report.
Huszno J, Piglowski W, Mazur M, Pamula-Pilat J, Zajkowicz A, Kierzkowska A
Mol Clin Oncol. 2021; 15(5):222.
PMID: 34548921
PMC: 8447178.
DOI: 10.3892/mco.2021.2385.
The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a systematic review and meta-analysis.
Moslemi M, Vafaei M, Khani P, Soheili M, Nedaeinia R, Manian M
Cancer Cell Int. 2021; 21(1):474.
PMID: 34493284
PMC: 8424893.
DOI: 10.1186/s12935-021-02172-8.
A right atrium metastasis of breast cancer after long-term endocrine therapy.
Xu F, Wang X, Jiang Z
Ann Transl Med. 2020; 7(22):702.
PMID: 31930103
PMC: 6944622.
DOI: 10.21037/atm.2019.09.36.
A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants.
Ticha I, Hojny J, Michalkova R, Kodet O, Krkavcova E, Hajkova N
Sci Rep. 2019; 9(1):17050.
PMID: 31745173
PMC: 6863855.
DOI: 10.1038/s41598-019-53636-x.
Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.
Lima Z, Ghadamzadeh M, Tahmasebi Arashloo F, Amjad G, Ebadi M, Younesi L
J Hematol Oncol. 2019; 12(1):38.
PMID: 30975222
PMC: 6460547.
DOI: 10.1186/s13045-019-0725-6.
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
Lin P, Kuo W, Huang A, Lu Y, Lin C, Kuo S
Oncotarget. 2016; 7(7):8310-20.
PMID: 26824983
PMC: 4884994.
DOI: 10.18632/oncotarget.7027.
Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma.
Havranek O, Kleiblova P, Hojny J, Lhota F, Soucek P, Trneny M
PLoS One. 2015; 10(10):e0140819.
PMID: 26506619
PMC: 4624763.
DOI: 10.1371/journal.pone.0140819.
The associations between Parkinson's disease and cancer: the plot thickens.
Feng D, Cai W, Chen X
Transl Neurodegener. 2015; 4:20.
PMID: 26504519
PMC: 4620601.
DOI: 10.1186/s40035-015-0043-z.
Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.
Bhandaru M, Martinka M, McElwee K, Rotte A
PLoS One. 2015; 10(8):e0134678.
PMID: 26275218
PMC: 4537129.
DOI: 10.1371/journal.pone.0134678.
ATM gene mutations in sporadic breast cancer patients from Brazil.
Mangone F, Miracca E, Feilotter H, Mulligan L, Nagai M
Springerplus. 2015; 4:23.
PMID: 25625042
PMC: 4298590.
DOI: 10.1186/s40064-015-0787-z.
Effect of single nucleotide polymorphism Rs189037 in ATM gene on risk of lung cancer in Chinese: a case-control study.
Liu J, Wang X, Ren Y, Li X, Zhang X, Zhou B
PLoS One. 2014; 9(12):e115845.
PMID: 25541996
PMC: 4277362.
DOI: 10.1371/journal.pone.0115845.
Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.
Abdel-Fatah T, Arora A, Alsubhi N, Agarwal D, Moseley P, Perry C
Neoplasia. 2014; 16(11):982-91.
PMID: 25425972
PMC: 4240925.
DOI: 10.1016/j.neo.2014.09.009.